🔎 Trials Near Me

Home › Bile Duct Cancer (Cholangiocarcinoma) › New Jersey › Edison

Bile Duct Cancer (Cholangiocarcinoma) clinical trials in Edison, NJ

5 studies for Bile Duct Cancer (Cholangiocarcinoma) are looking for participants at sites in and around Edison (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

RecruitingPhase 1
  • START New Jersey, East Brunswick · 6 mi away
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06270706

A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer

RecruitingPhase 3
  • Rutgers Cancer Institute of New Jersey (Site 103), New Brunswick · 3 mi away
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07265674

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

RecruitingPhase 1/2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi away
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07488676

Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery

RecruitingPhase 2
  • Memorial Sloan Kettering Basking Ridge - Limited Protocol Activities, Basking Ridge · 15 mi away
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT04891289

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study
  • Massive Bio SYNERGY-AI site, New Brunswick · 3 mi away
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

Bile Duct Cancer (Cholangiocarcinoma) trials in other cities

Other studies in Edison

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.